Figure 4.
Overall survival time in patients with HCC treated with Atez/Bev. (A) Kaplan–Meier curves for overall survival in the Atez/Bev-TACE sequential therapy group and the Atez/Bev monotherapy group. (B) Kaplan–Meier curves for overall survival in the Atez/Bev-TACE sequential therapy group and the Atez/Bev monotherapy group in patients with intermediate-stage HCC.
